edetic acid has been researched along with Disease Exacerbation in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 17 (70.83) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| El Backly, R; El-Gendy, R; Mahmoud, A; Moussa, S | 1 |
| Bellò, M; Ceci, F; Cerio, I; Deandreis, D; Dionisi, B; Finessi, M; Nicolotti, DG; Pilati, E; Zotta, M | 1 |
| Baumann, M; Hölscher, T; Kotzerke, J; Krause, M; Löck, S; Lohaus, F; Troost, EGC; Wirth, M; Zöphel, K | 1 |
| Fägerlind, M; Friman, S; Friman, V; Gäbel, M; Herlenius, G; Krantz, M; Mölne, J; Olausson, M; Oltean, M | 1 |
| Bäckman, L; Felldin, M; Fistouris, J; Friman, S; Herlenius, G; Olausson, M | 1 |
| Chen, KH; Hsu, CW; Hsu, HH; Hsu, KH; Lin, JL; Lin-Tan, DT; Yen, TH | 1 |
| Hsu, KH; Lin, JL; Lin-Tan, DT; Yu, CC | 1 |
| Alam, MG; Owda, AK; Shah, SV | 1 |
| Lopes, AA; Port, FK | 1 |
| Alvestrand, A; Elinder, CG | 1 |
| Moses, MA; Pories, SE; Roy, R; Wewer, UM; Zurakowski, D | 1 |
| Collier, F; Hall, M; Ham, H; Ismaili, K; Piepsz, A; Tondeur, M | 1 |
| Busby, E; Carey, D; Forero, A; Grizzle, WE; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Robert, F; Shen, S | 1 |
| Bjarnason, I; Björnsson, E; Johansson, JE; Kalaitzakis, E | 1 |
| Belloni, D; Ferrero, E; Ferrero, ME; Foglieni, C; Fulgenzi, A; Pellegatta, F; Sciorati, C; Ticozzi, P | 1 |
| Huang, YY; Li, KL; Li, YJ; Lin, JL; Lin-Tan, DT; Yu, CC | 1 |
| Aronson, M; Dalal, E; Hidas, G; Nativ, O | 1 |
| Chen, KH; Huang, YL; Lin, JL; Lin-Tan, DT; Yen, TH | 1 |
| Davin, JC; Kovács, T; Kun, L; Nagy, J; Schmelczer, M; Wagner, L | 1 |
| Ho, HH; Lin, JL; Yu, CC | 1 |
| Christensen, PK; Nielsen, FS; Parving, HH; Rossing, P | 1 |
| Hovind, P; Parving, HH; Rossing, P; Smidt, UM; Tarnow, L | 1 |
| Hsu, KH; Lin, JL; Tan, DT; Yu, CC | 1 |
| Eigenbrodt, E; Morr, H; Schneider, J; Velcovsky, HG; Weisse, G | 1 |
8 trial(s) available for edetic acid and Disease Exacerbation
| Article | Year |
|---|---|
Chronic kidney disease--a common and serious complication after intestinal transplantation.
Topics: Adult; Aged; Anti-Infective Agents; Child, Preschool; Chromium Radioisotopes; Chronic Disease; Digestive System Surgical Procedures; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Intestines; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Reoperation; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens.
Topics: Adult; Aged; Chelating Agents; Chelation Therapy; Creatinine; Diabetic Nephropathies; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Lead; Male; Middle Aged | 2012 |
Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
Topics: Adult; Aged; Aged, 80 and over; Chelation Therapy; Creatinine; Disease Progression; Edetic Acid; Environmental Exposure; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Lead; Lead Poisoning; Longitudinal Studies; Male; Middle Aged | 2003 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chelating Agents; Clinical Trials as Topic; Disease Progression; Edetic Acid; Female; Glycoproteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Pentetic Acid; Radioimmunotherapy; Radiometry; Thrombocytopenia; Treatment Outcome; Up-Regulation; Yttrium Radioisotopes | 2005 |
Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes.
Topics: Adult; Aged; Chelating Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Edetic Acid; Environmental Exposure; Female; Humans; Lead Poisoning; Male; Middle Aged; Prospective Studies | 2006 |
Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Chelating Agents; Chelation Therapy; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Lead; Lead Poisoning; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Renal Insufficiency; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2007 |
Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial.
Topics: Adult; Aged; Body Burden; Chelating Agents; Chelation Therapy; Creatinine; Disease Progression; Edetic Acid; Environmental Exposure; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lead Poisoning; Male; Middle Aged; Sensitivity and Specificity | 1999 |
Environmental lead exposure and progressive renal insufficiency.
Topics: Adolescent; Adult; Aged; Body Burden; Chelating Agents; Creatinine; Disease Progression; Edetic Acid; Environmental Exposure; Female; Follow-Up Studies; Humans; Kidney; Kidney Failure, Chronic; Lead; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Single-Blind Method | 2001 |
16 other study(ies) available for edetic acid and Disease Exacerbation
| Article | Year |
|---|---|
Investigating the residual effect of silver nanoparticles gel as an intra-canal medicament on dental pulp stromal cells.
Topics: Calcium Hydroxide; Dental Pulp; Disease Progression; Edetic Acid; Humans; Metal Nanoparticles; Root Canal Irrigants; Silver; Stromal Cells | 2022 |
68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
Topics: Aged; Disease Progression; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glioblastoma; Humans; Male; Neoplasm, Residual; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence | 2020 |
Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease?
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Databases, Factual; Disease Progression; Dose Fractionation, Radiation; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Kallikreins; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oligopeptides; Positron-Emission Tomography; Progression-Free Survival; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Time Factors | 2019 |
Early renal function post-liver transplantation is predictive of progressive chronic kidney disease.
Topics: Chelating Agents; Contrast Media; Disease Progression; Edetic Acid; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Iohexol; Kidney Failure, Chronic; Kidney Function Tests; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Period; Prognosis; Retrospective Studies; Risk Factors; Time Factors | 2008 |
Environmental lead exposure and chronic renal disease.
Topics: Chelation Therapy; Disease Progression; Edetic Acid; Environmental Exposure; Humans; Iron; Kidney Failure, Chronic; Lead; Lead Poisoning | 2003 |
Environmental lead exposure and chronic renal disease.
Topics: Black People; Chelation Therapy; Diabetes Complications; Disease Progression; Edetic Acid; Environmental Exposure; Humans; Kidney Failure, Chronic; Lead; Lead Poisoning | 2003 |
Environmental lead exposure and chronic renal disease.
Topics: Cadmium; Chelation Therapy; Confounding Factors, Epidemiologic; Disease Progression; Edetic Acid; Environmental Exposure; Humans; Kidney Failure, Chronic; Lead; Lead Poisoning; Occupational Exposure | 2003 |
ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
Topics: ADAM Proteins; ADAM12 Protein; Adult; Aged; Amino Acid Sequence; Animals; Blotting, Western; Breast Neoplasms; Caseins; Catalysis; Chelating Agents; Chromatography, Affinity; Chromatography, Ion Exchange; Collagen Type I; Collagen Type IV; COS Cells; Databases as Topic; Densitometry; Disease Progression; Edetic Acid; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Extracellular Matrix; Female; Fibronectins; Gelatin; Humans; Hydroxamic Acids; Immunoblotting; Membrane Proteins; Metalloendopeptidases; Middle Aged; Molecular Sequence Data; Neoplasm Metastasis; Peptides; Phenanthrolines; Plasmids; Recombinant Proteins; Sensitivity and Specificity; Sepharose; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substrate Specificity; Ultracentrifugation; Zinc | 2004 |
How to interpret a deterioration of split function?
Topics: Chelating Agents; Child; Child, Preschool; Disease Progression; Edetic Acid; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydronephrosis; Infant; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Radioisotope Renography; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Mertiatide | 2005 |
Intestinal permeability in cirrhotic patients with and without ascites.
Topics: Adult; Aged; Aged, 80 and over; Ascites; Chelating Agents; Disease Progression; Edetic Acid; Female; Humans; Intestinal Mucosa; Liver Cirrhosis; Male; Middle Aged; Permeability; Prognosis; Severity of Illness Index | 2006 |
Protective effect of EDTA preadministration on renal ischemia.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Capillary Permeability; Cell Adhesion; Chelating Agents; Creatinine; Disease Models, Animal; Disease Progression; Edetic Acid; Hemodynamics; Ischemia; Kidney; Macrophage-1 Antigen; Male; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2006 |
EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
Topics: Administration, Intravesical; Animals; Chelating Agents; Disease Models, Animal; Disease Progression; Edetic Acid; Female; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2006 |
Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability.
Topics: Adult; Antigens; Chromium; Disease Progression; Edetic Acid; Female; Follow-Up Studies; Food; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Intestinal Absorption; Male; Permeability | 1996 |
Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Cholesterol; Chromium Radioisotopes; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Kidney; Longitudinal Studies; Male; Middle Aged; Time Factors | 1999 |
Progression of diabetic nephropathy.
Topics: Adult; Albuminuria; Blood Pressure; Cholesterol; Diabetic Nephropathies; Disease Progression; Edetic Acid; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged | 2001 |
Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Clinical Enzyme Tests; Disease Progression; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Humans; Isoenzymes; Lung Diseases; Lung Diseases, Obstructive; Lung Neoplasms; Neoplasm Proteins; Pneumoconiosis; Pyruvate Kinase; Sensitivity and Specificity; Tuberculosis, Pulmonary | 2000 |